The Bellcast
Bridge the investing and markets knowledge gap with the Bell Direct Bellcast. From bite-size thought snippets, to full length interviews with the top executives of leading ASX200 companies, you'll be informed and ready for any market movement.
Episodes
In this episode of From the Helm, Bell Financial Group’s Grady Wulff sits down with Yojee (ASX:YOJ) CEO, Mark Connell, to discuss how the company is harnessing artificial intelligence and machine learning to lead innovation in logistics software. With shares climbing over the past year, Mark shares what’s driving growth and where Yojee is headed next.
In this conversation, Mark covers:
• (0:31): What Yojee does and how...
In this episode of From the Helm, Bell Financial Group’s Grady Wulff speaks with DroneShield (ASX: DRO) CEO, Oleg Vornik, about the company’s rapid momentum in FY25, key contract wins, and how it’s positioned as a leader in counter-drone technology amid heightened global defence spending.
In this video, Oleg covers:
• (0:58): FY25 momentum and major contract wins
• (2:09): $13m facility expansion and scaling plans<...
Join us for a tactical deep dive into the Defence sector in this special episode of our 2025 Meet the Analyst series.
Bell Direct’s Senior Market Analyst, Grady Wulff, sits down with Bell Potter Industrials Analyst, Daniel Laing, to explore one of the market’s most talked-about themes, defence stocks.
From unpacking global defence spending trends to identifying the standout stocks riding the drone warfare wave, in...
In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests.
In this video, Dr. Lipscombe covers:
· (0:47): An overview of PIQ and its FY26 goals
· (1:38): The significance of three wo...
In this episode of From the Helm, Bell Financial Group’s Grady Wulff speaks with Perseus Mining (ASX: PRU) CEO, Jeff Quartermaine, about the company’s strategic direction, growth projects across West Africa, and how it’s positioned amid a booming gold market.
In this video, Jeff covers:
• (0:37): how current gold market tailwinds are shaping its success
• (1:10): operating conditions in West Africa compared to...
In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Elsight (ASX: ELS) Director, Howard Digby, about the company’s AI-powered connectivity solutions and its role in the rapidly growing unmanned systems market.
In this video Howard covers:
• (0:33): Elsight’s current financial position and the path to profitability
• (4:07): capacity to meet demand and capital needs for expansion
• (5:13): how...
In this episode of the From the helm, Bell Financial Group’s Grady Wulff speaks with Flynn Gold (ASX: FG1) Managing Director, Neil Marston about the company’s high-grade gold discovery at the Golden Ridge project in Tasmania.
In this video Neil covers:
• (1:38): what Flynn Gold has uncovered at Golden Ridge
• (2:08): how it compares to other major goldfield projects
• (2:58): exploration upside and key milestones ahead
In this special edition of Bell Direct’s From the helm series, we take a closer look at LinQ Minerals – a company set to make waves with its upcoming IPO.
With investor interest in gold and copper ramping up, Bell Direct Market Analyst Grady Wulff speaks with Executive Chairman Clive Donner to discuss LinQ’s standout assets in NSW, recent high-grade drill results, and post-listing strategy.
In this video, Clive discusses:
• (0:30...
Join our Market Analyst, Grady Wulff as she sits down with Bell Potter's Analyst, John Hester as he discusses an update on the below healthcare stocks.
In this video, John discusses:
- (3:15) Telix's Pharmaceuticals (ASX:TLX)
- (7:34) Clarity Pharmaceuticals (ASX:CU6)
- (10:54) Avita Medical (ASX:AVH)
- (12:16) Mesoblast (ASX:MSB)
- (14:31) Promedicus (ASX:PME)
Note: This interview wa...
In this Bell Direct macro update, we break down the latest March quarter CPI figures and what they could mean for the RBA’s next move.
With trimmed mean inflation easing to within target and key categories like services and housing shifting, could a rate cut be on the horizon?
Watch now for expert analysis and market insights.
Join Market Analyst Grady Wulff as she sits down with Scott Kirkland, CEO and Managing Director of EMVision Medical Devices (ASX:EMV), to discuss how the company’s pioneering portable brain scanner is set to revolutionize stroke diagnosis and care.
In this video, Scott covers:
• (0:31) EMVision’s history and breakthrough technology
• (3:09) key trial results and development progress
• (8:54) US market oppo...
In this latest instalment of Bell Direct’s From the helm series, we kick off 2025 with an exciting deep dive into the healthcare sector. Host Bell Direct’s Market Analyst, Grady Wulff sits down with Opthea (ASX:OPT) CEO, Fred Guerard to discuss the company’s remarkable 168% share price surge over the past six months as it advances toward commercialising its novel retinal disease treatment, Sozinibercept. With an initial focus on we...
In today’s market update, we’re diving into the latest inflation numbers for Australia, with underlying inflation falling to its lowest level in 3 years at 3.2%, exceeding expectations and bringing it closer to the RBA’s target range. While CPI for the 12-months to December rose by 2.4%, we saw some sectors, like housing and transport, offsetting price increases in areas like recreation and alcohol. This decline in inflation raises...
Dive into the latest commodity trends with our Market Analyst Grady Wulff’s quarterly chat featuring Lion Selection Group (ASX:LSX) CEO, Hedley Widdup.
Gold’s 2024 Performance – What’s Next?
Gold dazzled in 2024, reaching record highs of US$2,697/oz. Can this momentum continue with Trump back in office? Hedley sees strong tailwinds ahead, fuelled by:
- inflation concerns and geopolitical uncertainty
- robust demand from China and...
Our Market Analyst, Grady Wulff, sits down over the next 6 minutes with 6 executives who are exploring all parts of the world from uranium to a gold and silver deposit discovered in Chile recently.
Watch Grady catch up with the following executives:
- (0:42) Neil McDonald, Managing Director - Gold Hydrogen
- (1:45) Rowan Johnston, Executive Chair - Kin Mining
- (2:28) Chris Byrne, Managing Director - Legacy Minerals
- (3:37) Siobh...
This audio was filmed by and belongs to the ASX.
Our Market Analyst, Grady Wulff, featured on the ASX The Ideas Exchange Podcast, hosted by Jacinta King.
In this episode, Grady talks about:
- Sector outlook
- How far can the tech rally go?
- Will gold remain popular in 2024?
- Consumer Discretionary surprised the market in 2023
- Opportunities to assess in 2024.
Be sure to listen to the episode on the ASX website h...
In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to DroneShield's (ASX:DRO) Managing Director and CEO, Oleg Vornik.
DroneShield is making waves in the capital goods industry through the use of artificial intelligence and machine learning. The company is an Australia defence manufacturer specialising in counter-drone technology, servicing military and intelligence, law enforcement, critical infras...
Live from the Resources Rising Stars conference on the Gold Coast, Bell Direct's Market Analyst, Grady Wulf, sat down with Liontown Resources (ASX:LTR) Chairman and mining magnate, Tim Goyder to discuss updates on the Kathleen lithium project, the Albemarle takeover and the company's outlook for the next 12 months. Hear it from the Helm here, as we collaborate with Resources Media to bring you the From the Helm Live at th...
Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.
In this video, Dr. Tara discusses:
- (0:34) Impacts of Ferring's FDA approval on Microba
- (5:30) Drivers behind Microba's increase in revenue
- (7:12) What 2023 looks like for Monash IVF
- (8:39) Monash IVF's rating
- (11:45)...
View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).
Take a look at Dr. Tara's journey, her approach to analysing a company, and the first stock to ...
Popular Podcasts
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Special Summer Offer: Exclusively on Apple Podcasts, try our Dateline Premium subscription completely free for one month! With Dateline Premium, you get every episode ad-free plus exclusive bonus content.
I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!
The latest news in 4 minutes updated every hour, every day.
Listen to 'The Bobby Bones Show' by downloading the daily full replay.